The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines

Schmidt, Andreas; Behrendt, Lucas; Eybe, Jana; Warmann, Steven W.; Schleicher, Sabine; Fuchs, Joerg; Schmid, Evi

dc.contributor.author	Schmidt, Andreas
dc.contributor.author	Behrendt, Lucas
dc.contributor.author	Eybe, Jana
dc.contributor.author	Schleicher, Sabine Barbara
dc.contributor.author	Schmid, Evi
dc.contributor.author	Warmann, Steven
dc.contributor.author	Fuchs, Jörg
dc.date.accessioned	2023-02-28T10:26:49Z
dc.date.available	2023-02-28T10:26:49Z
dc.date.issued	2022
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/137092
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers14010041	de_DE
dc.subject.ddc	610	de_DE
dc.title	The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02662
utue.personen.roh	Schmidt, Andreas
utue.personen.roh	Behrendt, Lucas
utue.personen.roh	Eybe, Jana
utue.personen.roh	Warmann, Steven W.
utue.personen.roh	Schleicher, Sabine
utue.personen.roh	Fuchs, Joerg
utue.personen.roh	Schmid, Evi
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 41	de_DE
dcterms.isPartOf.ZS-Volume	14 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE